| Incyte Biosciences International Sàrl - Pemazyre 13,5 mg, comprimés |
| 68143 | | 03 | | Pemazyre 13,5 mg | | comprimés | | L01EN02 | | | | 13.07.2021 | | |
|
| Composition |
| pemigatinibum 13.5 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.528 mg, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Pemigatinibum | 13.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Pemigatinibum | 13.5 mg |
| | | | Agents auxilliaires |
|---|
| Carboxymethylamylum Natricum A | | Cellulosum Microcristallinum | | Magnesii Stearas | | Pro Compresso |
| |
|
|
